Maeng CH
No ORCID on file
· 1 paper in corpus
· active 2020
Top journals
Frequent coauthors
2020
BackgroundLenvatinib, a novel multi-target tyrosine kinase inhibitor, has been approved for treating differentiated thyroid cancer. Herein, we describe a rare case of acute pancreatitis that developed during lenvatinib treatment in a 65-yea…